Live-cell intracellular immunofluorescence

活细胞细胞内免疫荧光

基本信息

批准号：
10285673
负责人：
Xiaohu Gao
金额：
$ 18.17万
依托单位：
UNIVERSITY OF WASHINGTON
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-08-10 至 2023-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10285673
关键词：
Actins Antibodies Binding Biological Biological Markers Biological Process Biology Bypass Cations Cell Nucleus Cell Signaling Process Cell membrane Cell physiology Cells Cellular Structures Charge Chimeric Proteins Cholesterol Clinical Complex Cytoplasm Cytosol DNA Data Diffuse Dimensions Endocytosis Endosomes Evolution Exposure to Flow Cytometry Fluorescent Antibody Technique Future Goals Gold Growth Human body Image Immunofluorescence Immunologic Immunoglobulin Fragments Immunohistochemistry Immunologics Individual Intracellular Space Label Learning Lipids Liposomes Lysosomes Membrane Metabolism Molecular Molecular Biology Nature Organism Pathologic Processes Pathway interactions Peptides Polymers Process Production Proteins Protocols documentation RNA Reproduction Research Resolution Sampling Science Signal Transduction Specificity Surface System Technology Time base cell fixing cellular engineering cytotoxicity drug development fluorescence imaging hydrophilicity imaging agent imaging probe innovation interest invention live cell imaging macromolecule nanobodies preservation prevent protein function real-time images small molecule temporal measurement three dimensional structure tool

项目摘要

ABSTRACT Immunofluorescence (IF) is one of the most important tools for both basic biology research and clinical sample imaging due to the broad availability of antibodies and the resolution and sensitivity of fluorescence imaging. Despite the tremendous amount of data produced by IF in the past ~60 years since its initial invention, IF suffers from a fundamental limitation: incapability of interrogating intracellular targets in live cells (cells have to be fixed first, thus only providing a snapshot of the dynamic cell signaling process). Considering the 3D structure of cells, there are far more intracellular targets with biological significance than their cell-membrane counterparts, but immunological agents such as antibodies, antibody fragments, peptides, nanobodies, and scFvs, being highly hydrophilic macromolecules, cannot spontaneously cross the cell membranes. To overcome the barriers of cell membrane and endocytosis that are extremely effective in preventing intact biomolecules to enter the cytosol, we propose to develop an intracellular protein delivery technology building on a unique concept: non- covalent cholesterol tagging. In contrast to conventional delivery technologies that are mostly based on endocytosis (inappropriate for live cell imaging due to the high background generated by imaging agents trapped in endosomes), our small-molecule tag enables proteins to permeate through the cell membrane. More importantly, this is achieved without generating pores in the membrane that cause cytotoxicity. If successful, this platform technology should open a whole new dimension for molecular biology, drug development, and cell engineering.

抽象的免疫荧光 (IF) 是基础生物学研究和临床样本最重要的工具之一成像由于抗体的广泛可用性以及荧光成像的分辨率和灵敏度。尽管自最初发明以来 IF 在过去约 60 年里产生了大量数据，但 IF 仍面临着一些问题来自一个根本的限制：无法询问活细胞中的细胞内靶标（细胞必须是首先固定，因此仅提供动态小区信令过程的快照）。考虑到 3D 结构细胞中具有生物学意义的细胞内靶标比细胞膜靶标多得多，但免疫制剂，例如抗体、抗体片段、肽、纳米抗体和 scFv，高亲水性大分子，不能自发穿过细胞膜。克服障碍细胞膜和内吞作用对于防止完整生物分子进入细胞非常有效细胞质中，我们建议开发一种基于独特概念的细胞内蛋白质递送技术：非共价胆固醇标记。与主要基于内吞作用（由于捕获的成像剂产生高背景，不适合活细胞成像在内体中），我们的小分子标签使蛋白质能够渗透细胞膜。更多的重要的是，这是在膜上不产生导致细胞毒性的孔的情况下实现的。如果成功的话，这平台技术将为分子生物学、药物开发和细胞打开一个全新的维度工程。